Healthcare CIOs View AI as Strategic Imperative, but Scaling Barriers Persist

Artificial intelligence is rapidly becoming a strategic necessity for healthcare organizations, yet most health systems remain constrained in their ability to scale deployments beyond pilot programs, according to a new industry report.

A study released by Qventus finds that while healthcare leaders broadly recognize AI’s potential to transform operations and patient care, significant execution challenges continue to limit enterprise-wide adoption.

Widespread Adoption, Limited Maturity

The report, based on interviews and surveys of more than 60 senior healthcare IT leaders—including chief information officers, chief AI officers, and chief medical information officers—reveals a sector still in transition.

Although 42% of organizations report deploying AI across multiple use cases, only 4% have successfully scaled AI with measurable outcomes. Meanwhile, 45% of respondents cited difficulties in moving beyond pilot phases, underscoring a persistent gap between experimentation and operationalization.

Additionally, one in four organizations acknowledged lacking formal processes to benchmark AI performance, raising concerns about how success is defined and measured.

EHR Dependency Slows Execution

A key obstacle identified in the report is reliance on electronic health record (EHR) vendors. Approximately 74% of respondents said dependency on vendor roadmaps is impeding AI progress, as organizations wait for embedded capabilities rather than deploying independent solutions.

Compounding the issue is the growing complexity of managing multiple third-party AI tools, which can create integration challenges and hinder scalability across health systems.

Competitive Pressure Intensifies

Despite these barriers, healthcare leaders overwhelmingly agree that AI adoption is no longer optional. The report indicates that 94% of respondents believe delaying AI implementation will result in a competitive disadvantage, while 68% say it could exacerbate clinician burnout.

Organizations are increasingly shifting their focus toward tangible returns, with 62% prioritizing revenue generation and 59% emphasizing cost savings as key indicators of AI success.

Shift Toward Automation and Platform Consolidation

Health systems are also exploring more advanced use cases, including agentic and autonomous AI platforms capable of managing scheduling, patient flow, and care coordination tasks with minimal human intervention.

Industry experts suggest that scaling AI effectively will require a move away from fragmented point solutions toward integrated, enterprise-level platforms that can support multiple applications within a unified infrastructure.

Trust Gap Between Clinicians and Patients

Separate research from EBSCO Clinical Decisions highlights a divergence in attitudes toward AI adoption.

While clinicians report high levels of trust in AI-powered clinical decision support tools—and frequent use in patient care—consumer sentiment remains more cautious. A majority of surveyed patients indicated a preference for providers who do not rely on AI, pointing to an ongoing trust gap that could influence adoption.

Mounting Systemic Pressures

The urgency to operationalize AI is further heightened by broader structural challenges facing the healthcare sector, including workforce shortages, financial constraints, and a rapidly aging population.

These pressures are expected to intensify in the coming decades, increasing demand for scalable, technology-driven solutions.

High Stakes for Strategic Decisions

Healthcare leaders also caution that AI investments carry significant financial risk. In an industry characterized by narrow margins, unsuccessful technology bets can have outsized consequences, making governance and strategic alignment critical.